
TOKYO -- A noted Japanese stem cell researcher has asked Fujifilm Holdings to keep fees in check for using patented technology related to induced pluripotent stem cells, he told The Nikkei on Wednesday.
Stem cell pioneer wary of patent fees impeding regenerative medicine
TOKYO -- A noted Japanese stem cell researcher has asked Fujifilm Holdings to keep fees in check for using patented technology related to induced pluripotent stem cells, he told The Nikkei on Wednesday.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.